Delivery Order HHSN261201500003I-HHSN26100009
Ended Awarded Last action
- Contract number
- HHSN26100009
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,068,609
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $2,068,609.35 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $39,058 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $29,551 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,000,000 |
About this award
This is a delivery order federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for $2,068,609.35 and supports the development of tuberculosis vaccines. The work will be performed at Leidos Biomedical Research facilities in Frederick, Maryland. This contract does not have a set-aside designation. Leidos Biomedical Research Inc. is an FFRDC (Federally Funded Research and Development Center) contractor for the National Cancer Institute, providing a range of biomedical research and facilities support services to federal agencies, particularly within the NIH. The parent company, Leidos Holdings, Inc., is a global leader in information technology, engineering, and science solutions, with a history of providing subcontractor services to prime contractors on federal contracts.
Quick answers
Who was awarded contract HHSN26100009?
HHSN26100009 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 26, 2015.
How much is contract HHSN26100009 worth?
The government has obligated $2,068,609 on HHSN26100009.
Which agency awarded contract HHSN26100009?
National Cancer Institute (National Institutes of Health) awarded HHSN26100009, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract HHSN26100009 an order under another contract?
Yes. HHSN26100009 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100009 competed?
The extent of competition for HHSN26100009 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award